title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,SKXJF,0.013173,Neutral,-0.019011
Esperion  ( ESPR )  Settles Milestone Dispute With Daiichi Sankyo,20240104T160800,https://www.zacks.com/stock/news/2205756/esperion-espr-settles-milestone-dispute-with-daiichi-sankyo,SKXJF,0.060388,Neutral,0.088
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,SKXJF,0.046184,Neutral,-0.012968
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,SKXJF,0.065268,Neutral,-0.0392
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,SKXJF,0.078099,Neutral,0.0
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,SKXJF,0.043108,Neutral,0.0
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,SKXJF,0.041791,Neutral,0.034859
Gilead Sciences  ( GILD )  Q4 2022 Earnings Call Transcript,20230203T020023,https://www.fool.com/earnings/call-transcripts/2023/02/02/gilead-sciences-gild-q4-2022-earnings-call-transcr/,SKXJF,0.004354,Neutral,0.072867
"With 14.1% CAGR, Monoclonal Antibody Therapy Market Size Worth USD 451.89 Billion by 2028",20230130T105418,https://www.benzinga.com/pressreleases/23/01/g30618366/with-14-1-cagr-monoclonal-antibody-therapy-market-size-worth-usd-451-89-billion-by-2028,SKXJF,0.035983,Somewhat-Bearish,-0.268668
Why MacroGenics Stock Sank Today,20220912T231457,https://www.fool.com/investing/2022/09/12/why-macrogenetics-stock-sank-today/,SKXJF,0.254307,Neutral,0.090638
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Summit Therapeutics  ( NASDAQ:SMMT ) ,20240909T100836,https://www.benzinga.com/news/24/09/40768801/why-summit-therapeutics-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket,SKXJF,0.063594,Somewhat-Bearish,-0.203312
